Recent News

• 04.11.2025 - DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
• 04.11.2025 - DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024
• 03.28.2025 - DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin® Peanut jusqu’au dépôt d'une Demande de Licence Biologique (BLA) et d’assurer la...
• 03.28.2025 - DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
• 03.24.2025 - DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
• 03.24.2025 - DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…
• 02.25.2025 - DBV Technologies participera au prochain congrès conjoint AAAAI/WAO
• 02.25.2025 - DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress

Recent Filings

• 04.11.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.08.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.07.2025 - 3 Initial statement of beneficial ownership of securities
• 04.07.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.31.2025 - 8-K Current report
• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405